Concepedia

Mengjie Hu

MH

Statistics

Publications

18

Citations

1.6K

H-Index

16

Active since

2013

Affiliations

Xiamen University(Current)

Duke University

Monash University

Sanford Burnham Prebys Medical Discovery Institute

Duke Medical Center

Mengjie Hu is an author at Xiamen University specializing in life sciences, pharmacology, and molecular oncology.

ORCID

Publications per year

2013–2023

18

Publications

18

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Xinjian Liu, Xuhui Bao, Mengjie Hu et al. · Nature · 2020 · 500 citations · Full text

, , +12

Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy

Mengjie Hu, Qiang Luo, Gulimiran Alitongbieke et al. · Molecular Cell · 2017 · 314 citations · Full text

, , +16

ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation

Mengjie Hu, Min Zhou, Xuhui Bao et al. · Journal of Clinical Investigation · 2020 · 243 citations · Full text

, , +17

Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production

Mengjie Hu, Keith E. Schulze, Reena Ghildyal et al. · eLife · 2019 · 84 citations · Full text

, , +17

p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival

Mengjie Hu, Simon Crawford, Darren C. Henstridge et al. · Biochemical Journal · 2013 · 68 citations · Full text

, , +14

1–5 of 18